Regeneron Pharmaceuticals and Sanofi's Dupilumab received approval from the U.S. Food and Drug Administration for a treatment of an esophagus inflammation condition in younger children. The ...

Eosinophilic esophagitis (EoE) is a condition that affects the esophagus — the tube that carries food and liquid from the mouth to the stomach. It happens when the body’s immune system overreacts to ...

Pill esophagitis, or drug-induced esophagitis, occurs when oral medications cause inflammation in the esophagus, the tube that carries food from the throat to the stomach. Symptoms can range from mild ...

Eosinophilic esophagitis is a chronic, progressive disease in which the esophagus becomes inflamed due to a buildup of eosinophils, creating difficulty swallowing and eating. Dupilumab is a monoclonal ...

Radiation esophagitis, characterized by the inflammation of the esophagus, is the most common acute adverse effect of radiation therapy that causes swallowing problems. This eventually causes ...

Jan 25 (Reuters) - The U.S. health regulator has approved the use of Regeneron (REGN.O), opens new tab and Sanofi's (SASY.PA), opens new tab Dupixent to treat an allergic inflammation of the esophagus ...

Acid reflux occurs when acid flows up from the stomach into the esophagus (food tube) and the mouth. Although occasional acid reflux is common, gastroesophageal reflux disease (GERD) may be diagnosed ...

A three-step plan to beat inflammation! Identify your specific type, set your lifestyle up to avoid triggers, and cook tailored recipes designed to help you heal. Functional medicine practitioner ...

Feb 12 (Reuters) - Takeda Pharmaceutical's (4502.T), opens new tab therapy for an allergic inflammation of the esophagus has received approval from the U.S. FDA, the Japanese drugmaker said on Monday, ...